GSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancerGSK beats Merck to first PD-1 approval in newly diagnosed endometrial cancer - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on July 31, 2023 at 6:42 PM in business No comments 17